News Roundup: Pricing and Access for HIV Drug Daraprim

By Sean Dickson September 24, 2015

Recently, there has been substantial media attention to a price increase for Daraprim (pyrimethamine), a drug used to treat toxoplasmosis in patients with HIV. We are tracking developments as they unfold and have asked for a federal investigation into Daraprim pricing and access.

Below are links to news coverage of the price increase, Turing’s backing down from the price increase, interviews with Turing’s CEO, and coverage of the CEO’s problematic history with drug pricing. Also, please find an article describing how the manufacturer of cycloserine, a drug used to treat TB, recently reduced the price following activist pressure. 

If you have questions or have any challenges accessing Daraprim, please contact NASTAD staff member, Sean Dickson, for assistance.

Again, please contact Sean Dickson, Manager, Health Care Access, if you have any questions.